GNH USA

Europe — EMA

Montelukast Aurobindo Pharma (Malta)

GNH USA supplies Montelukast Aurobindo Pharma (Malta) (Montelukast), a leukotriene receptor antagonist for asthma and allergic rhinitis. Request a quote.

Montelukast

Request sourcing

1
Pack/s

What is Montelukast?

Montelukast, the active ingredient in Montelukast Aurobindo Pharma (Malta), is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is used to manage asthma, allergic rhinitis, and exercise‑induced bronchoconstriction in adults and children as directed by a healthcare professional.

GNH USA supplies Montelukast Aurobindo Pharma (Malta) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand through reliable logistics networks.

What is Montelukast used for?

Montelukast is a leukotriene receptor antagonist used to treat conditions mediated by cysteinyl leukotrienes.

Asthma: reduces frequency of bronchospasm and improves overall control. Allergic rhinitis: alleviates nasal congestion, sneezing and itching. Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity. Seasonal allergic rhinitis: controls symptoms during pollen seasons. Perennial allergic rhinitis: reduces year‑round nasal symptoms.

What are the side effects of Montelukast?

Montelukast may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain in the head. - Abdominal pain: discomfort or cramps in the stomach area. - Nausea: feeling of queasiness. - Diarrhea: loose stools. - Dizziness: sensation of light‑headedness. - Upper respiratory tract infection: sore throat or runny nose. - Fever: mild increase in body temperature.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Neuropsychiatric events: agitation, depression, or suicidal thoughts. - Liver enzyme elevation: abnormal liver function tests.

What precautions apply to Montelukast?

When prescribing or dispensing Montelukast, consider the following precautions.

Dose adjustment: not required for renal or hepatic impairment, but monitor clinical response. Pregnancy: safety not established; use only if benefit outweighs risk. Breastfeeding: unknown; consider risk vs benefit. Concomitant asthma therapy: continue other controller medications; do not discontinue inhaled steroids. Avoid in patients with known hypersensitivity to montelukast or any excipients. Store at room temperature: keep in original container, protect from moisture and direct sunlight.

What does Montelukast interact with?

Montelukast can interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Phenobarbital: may reduce montelukast plasma concentrations. - Rifampin: induces metabolism leading to decreased efficacy. - Carbamazepine: may lower drug levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential for altered INR, monitor coagulation. - Erythromycin: may increase montelukast exposure, watch for side effects. - Fluconazole: possible increase in drug levels, adjust monitoring.

Frequently asked questions

What is Montelukast used for?+
Montelukast is prescribed to treat asthma, allergic rhinitis (both seasonal and perennial) and to prevent exercise‑induced bronchoconstriction. It works as a controller medication that reduces airway inflammation and hyper‑responsiveness, helping patients achieve better symptom control.
How does Montelukast work?+
Montelukast blocks the cysteinyl leukotriene receptor type 1 (CysLT1) on cells in the respiratory tract. By preventing leukotriene D4 from binding, it stops the cascade that causes bronchoconstriction, mucus production, vascular leakage and recruitment of inflammatory cells, thereby easing airway narrowing and inflammation.
What is the usual dose of Montelukast?+
The exact dose of Montelukast is determined by the prescribing healthcare professional based on the patient’s age, condition and clinical response. Standard dosing guidelines exist, but the prescriber tailors the regimen to each individual and provides specific instructions.
Is Montelukast safe in pregnancy or breastfeeding?+
Safety data for Montelukast during pregnancy are limited, and the medication is not classified as safe or unsafe. It should only be used if the potential benefit justifies any possible risk to the fetus. Information on use while breastfeeding is also insufficient; a risk‑benefit assessment should be performed by the clinician.
How do I order Montelukast Aurobindo Pharma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity of Montelukast Aurobindo Pharma (Malta). GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Montelukast compare with the main alternative drug or class?+
Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists for asthma control. Compared with other leukotriene antagonists such as zafirlukast, Montelukast has a once‑daily dosing schedule and a broader approval for allergic rhinitis, but efficacy is generally comparable across the class.
What are the recommended storage and handling conditions for Montelukast?+
Montelukast tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep them away from excess moisture, direct sunlight and heat sources. Do not store in the bathroom or near a kitchen sink where humidity is high.
How is Montelukast administered?+
Montelukast is supplied as an oral tablet that should be swallowed whole with a glass of water. It is taken once daily, preferably in the evening, unless the prescriber advises a different schedule. The tablet should not be crushed, chewed or split unless specifically instructed.
What are the most serious risks to watch for while taking Montelukast?+
Serious adverse reactions include neuropsychiatric events such as agitation, depression, suicidal thoughts, and rare allergic reactions that may present as rash, swelling or anaphylaxis. Liver enzyme elevations have also been reported. Patients should seek immediate medical attention if they experience any of these symptoms.
Who should not use Montelukast?+
Montelukast should be avoided in individuals with a known hypersensitivity to the drug or any of its excipients. It is also not recommended for patients who cannot safely swallow tablets without appropriate medical guidance. The prescriber should evaluate each patient’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Montelukast
Route
Oral Use
Manufacturer
Aurobindo Pharma (Malta) Limited
Origin
EU

Related products

MONTELUKAST SODIUM 5 mg/1

MONTELUKAST SODIUM 5 mg/1

Montelukast · 5 mg

Montelukast Sodium
TABLET, CHEWABLE
Ajanta Pharma USA Inc.
USA
MONTELUKAST SODIUM 5 mg/1

MONTELUKAST SODIUM 5 mg/1

Montelukast · 5 mg

Montelukast Sodium
TABLET, CHEWABLE
Ajanta Pharma USA Inc.
USA
Montelukast 10 mg/1

Montelukast 10 mg/1

Montelukast · 10 mg

Montelukast
TABLET
Macleods Pharmaceuticals Limited
USA
Montelukast 10 mg/1

Montelukast 10 mg/1

Montelukast · 10 mg

Montelukast
TABLET
Macleods Pharmaceuticals Limited
USA